Rabies vaccine + Rabies vaccines + Rabies immunoglobulins + Rabies vaccine + Rabies vaccines + Rabies immunoglobulins

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Rabies Infection

Conditions

Rabies Infection

Trial Timeline

Jun 1, 2014 → Aug 1, 2015

NCT ID

NCT02177032

About Rabies vaccine + Rabies vaccines + Rabies immunoglobulins + Rabies vaccine + Rabies vaccines + Rabies immunoglobulins

Rabies vaccine + Rabies vaccines + Rabies immunoglobulins + Rabies vaccine + Rabies vaccines + Rabies immunoglobulins is a phase 3 stage product being developed by Novartis for Rabies Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT02177032. Target conditions include Rabies Infection.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02177032	Phase 3	Completed	Jun 1, 2014	Aug 1, 2015	Rabies Infection

Competing Products

20 competing products in Rabies Infection

See all competitors

Product	Company	Stage	Hype Score
Abbreviated Zagreb 2-1-1 schedule + Standard Essen 1-1-1-1-1 schedule	Novartis	Phase 3	77
Three 1 mL doses of Rabies vaccine and two JE vaccine + Three 0.5 mL doses of Rabies vaccine and two JE vaccine + Three 0.1mL doses of Rabies Vaccine and two JE vaccine + Two 0.1mL doses of Rabies vaccine and two JE vaccine + Two doses of JE vaccine	Novartis	Phase 2	52
Zagreb + Essen	Novartis	Phase 3	77
rabies vaccine	Novartis	Phase 3	77
Rabies + Japanese Encephalitis	Novartis	Phase 3	77
Purified Chick Embryo Cell Inactivated Rabies Vaccine	Novartis	Approved	85
Intramuscular (IM) rabies post-exposure prophylaxis + Intradermal (ID) rabies post-exposure prophylaxis	Sanofi	Pre-clinical	22
Purified vero rabies vaccine - serum free + Purified inactivated rabies vaccine + Human rabies immunoglobulins	Sanofi	Phase 3	76
VRVg-2 + Purified Inactivated Rabies Vaccine + Human Diploid Cell Vaccine (HDCV) + Rabies immune globulin (human)	Sanofi	Phase 3	76
Purified vero rabies vaccine - serum free - VRVg-2 + Purified inactivated rabies vaccine - Verorab® + Purified inactivated rabies vaccine - Imovax® Rabies	Sanofi	Phase 3	76
HDCV + HDCV + PVRV + PVRV	Sanofi	Phase 3	76
Purified Vero Rabies Vaccine (VRVg) - Serum Free + Imovax® Rabies: inactivated rabies vaccine	Sanofi	Phase 2	51
Purified inactivated rabies vaccine, serum free + Purified inactivated rabies vaccine, serum free + Purified Vero Rabies Vaccine + Purified Vero Rabies Vaccine	Sanofi	Phase 3	76
Purified Vero Rabies Vaccine Serum Free (VRVg) + Imovax® Rabies: Human Diploid Cell Vaccine (HDCV),	Sanofi	Phase 2	51
Purified vero rabies vaccine - serum free VRVg-2 + Purified inactivated rabies vaccine + Equine rabies immunoglobulins (ERIG) (only Group 3 and Group 4) + Human rabies immunoglobulins (HRIG) (only Group 5 and Group 6)	Sanofi	Phase 3	76
Purified Vero Rabies Vaccine (VRVg) + Imovax® Rabies: inactivated rabies vaccine	Sanofi	Phase 2	51
Purified Verocell Rabies Vaccine + Purified Verocell Rabies Vaccine + Purified Verocell Rabies Vaccine	Sanofi	Approved	84
VRVg 2 + VRVg 1 + Imovax Rabies + VRVg 2 + VRVg 2 + Human Rabies Immunoglobulins (HRIG)	Sanofi	Phase 2	51
Purified Vero Rabies Vaccine - Serum Free + Purified inactivated rabies vaccine	Sanofi	Phase 2	51
PVRV + PVRV and pERIG Favirab® + PVRV and pERIG Favirab®	Sanofi	Phase 3	76

Other Products from Novartis

LCZ696Approved

zoledronic acidApproved

NateglinideApproved

TenofovirApproved

FTY720Approved